Treatment strategies for hormone receptor-positive, human epidermal growth factor receptor 2-positive (HR+/HER2+) metastatic breast cancer: A review
Last Updated: Friday, July 17, 2026
This review article discusses the results of preclinical and clinical studies in metastatic HR+/HER2+ breast cancer, highlights current treatment approaches, and explores de-escalation strategies and the search for prognostic and predictive biomarkers.